{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tests de cytotoxicité immunologique : Questions médicales les plus fréquentes",
"headline": "Tests de cytotoxicité immunologique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tests de cytotoxicité immunologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-16",
"dateModified": "2026-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tests de cytotoxicité immunologique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tests de toxicité",
"url": "https://questionsmedicales.fr/mesh/D018675",
"about": {
"@type": "MedicalCondition",
"name": "Tests de toxicité",
"code": {
"@type": "MedicalCode",
"code": "D018675",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.940"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tests de cytotoxicité immunologique",
"alternateName": "Cytotoxicity Tests, Immunologic",
"code": {
"@type": "MedicalCode",
"code": "D003601",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Recep Liman",
"url": "https://questionsmedicales.fr/author/Recep%20Liman",
"affiliation": {
"@type": "Organization",
"name": "Usak University Faculty of Arts and Sciences, Molecular Biology and Genetics Department, 1 Eylül Campus, 64300 Uşak, Turkey. Electronic address: recep.liman@usak.edu.tr."
}
},
{
"@type": "Person",
"name": "İbrahim Hakkı Ciğerci",
"url": "https://questionsmedicales.fr/author/%C4%B0brahim%20Hakk%C4%B1%20Ci%C4%9Ferci",
"affiliation": {
"@type": "Organization",
"name": "Afyon Kocatepe University, Faculty of Science and Literatures, Molecular Biology and Genetics Department, 03200 Afyonkarahisar, Turkey."
}
},
{
"@type": "Person",
"name": "Muhammad Muddassir Ali",
"url": "https://questionsmedicales.fr/author/Muhammad%20Muddassir%20Ali",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan. muddassir.ali@uvas.edu.pk."
}
},
{
"@type": "Person",
"name": "Claudio Gatto",
"url": "https://questionsmedicales.fr/author/Claudio%20Gatto",
"affiliation": {
"@type": "Organization",
"name": "Research and Development Department of AL.CHI.MI.A. S.r.l., Ponte San Nicolò (PD)35020, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Successful demand management in diagnostic immunology testing.",
"datePublished": "2024-03-20",
"url": "https://questionsmedicales.fr/article/36535742",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/jcp-2022-208334"
}
},
{
"@type": "ScholarlyArticle",
"name": "HIV rapid tests Immunological internal control can be misleading.",
"datePublished": "2024-05-30",
"url": "https://questionsmedicales.fr/article/38823441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pharma.2024.05.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Cytotoxicity Assay as an Alternative to the Murine Model for the Potency Testing of",
"datePublished": "2024-03-04",
"url": "https://questionsmedicales.fr/article/38438161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/02611929241237518"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37138382",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/path.6083"
}
},
{
"@type": "ScholarlyArticle",
"name": "Resist Acineto rapid immunological test for the detection of acquired carbapenemase producers among Acinetobacter spp.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37657230",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.diagmicrobio.2023.116043"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tests de toxicité",
"item": "https://questionsmedicales.fr/mesh/D018675"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tests de cytotoxicité immunologique",
"item": "https://questionsmedicales.fr/mesh/D003601"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tests de cytotoxicité immunologique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tests de cytotoxicité immunologique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tests de cytotoxicité immunologique",
"description": "Comment les tests de cytotoxicité sont-ils utilisés en diagnostic ?\nQuels types de maladies peuvent être diagnostiqués ?\nQuel échantillon est nécessaire pour ces tests ?\nLes tests sont-ils spécifiques à certaines cellules ?\nQuelle est la méthode de base utilisée dans ces tests ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tests de cytotoxicité immunologique",
"description": "Quels symptômes peuvent indiquer un problème immunitaire ?\nLes tests révèlent-ils des symptômes immédiats ?\nPeut-on prédire des symptômes futurs avec ces tests ?\nLes symptômes varient-ils selon les maladies ?\nLes tests peuvent-ils aider à surveiller des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tests de cytotoxicité immunologique",
"description": "Peut-on prévenir les maladies avec ces tests ?\nQuels comportements peuvent réduire les risques ?\nLes tests sont-ils recommandés pour les groupes à risque ?\nLes vaccinations influencent-elles les résultats des tests ?\nLes tests peuvent-ils guider des stratégies préventives ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tests de cytotoxicité immunologique",
"description": "Comment les résultats influencent-ils le traitement ?\nQuels traitements peuvent être évalués par ces tests ?\nLes tests peuvent-ils prédire l'efficacité d'un traitement ?\nLes résultats peuvent-ils changer le type de traitement ?\nLes tests sont-ils utilisés pour surveiller les effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tests de cytotoxicité immunologique",
"description": "Quelles complications peuvent survenir avec des tests ?\nLes tests peuvent-ils aggraver des conditions existantes ?\nY a-t-il des risques liés à la manipulation des échantillons ?\nLes complications sont-elles fréquentes ?\nComment minimiser les complications lors des tests ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tests de cytotoxicité immunologique",
"description": "Quels facteurs augmentent le risque de maladies immunitaires ?\nLe mode de vie influence-t-il le risque ?\nLes tests sont-ils recommandés pour les personnes à risque ?\nLes maladies chroniques augmentent-elles le risque ?\nLes antécédents médicaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D003601#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les tests de cytotoxicité sont-ils utilisés en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier des dysfonctionnements immunitaires ou des infections."
}
},
{
"@type": "Question",
"name": "Quels types de maladies peuvent être diagnostiqués ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour des maladies auto-immunes, infections virales et cancers."
}
},
{
"@type": "Question",
"name": "Quel échantillon est nécessaire pour ces tests ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de sang ou de tissus sont généralement requis pour l'analyse."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils spécifiques à certaines cellules ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent cibler des lymphocytes T, NK ou d'autres cellules immunitaires."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de base utilisée dans ces tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méthode de libération de la lactate déshydrogénase (LDH) est courante."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème immunitaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, infections fréquentes, et éruptions cutanées peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Les tests révèlent-ils des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils mesurent la réponse immunitaire, pas les symptômes directs."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes futurs avec ces tests ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent indiquer un risque accru de maladies, mais pas de symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent de la maladie sous-jacente et de la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les tests peuvent-ils aider à surveiller des symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent suivre l'évolution de certaines maladies immunitaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies avec ces tests ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne préviennent pas directement, mais aident à identifier les risques précoces."
}
},
{
"@type": "Question",
"name": "Quels comportements peuvent réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice et la vaccination peuvent renforcer l'immunité."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils recommandés pour les groupes à risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque élevé peuvent bénéficier d'une évaluation régulière."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les résultats des tests ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent améliorer la réponse immunitaire mesurée par les tests."
}
},
{
"@type": "Question",
"name": "Les tests peuvent-ils guider des stratégies préventives ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à élaborer des stratégies de prévention personnalisées."
}
},
{
"@type": "Question",
"name": "Comment les résultats influencent-ils le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à choisir des thérapies ciblées pour améliorer la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent être évalués par ces tests ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements immunothérapeutiques et les chimiothérapies sont souvent évalués."
}
},
{
"@type": "Question",
"name": "Les tests peuvent-ils prédire l'efficacité d'un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent indiquer la probabilité de succès d'un traitement immunitaire."
}
},
{
"@type": "Question",
"name": "Les résultats peuvent-ils changer le type de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des résultats anormaux peuvent mener à un changement de stratégie thérapeutique."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils utilisés pour surveiller les effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à évaluer les effets secondaires des traitements immunitaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des tests ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques ou des infections au site de prélèvement peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les tests peuvent-ils aggraver des conditions existantes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, ils peuvent exacerber des maladies auto-immunes ou inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la manipulation des échantillons ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une manipulation incorrecte peut entraîner des résultats faussement négatifs."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares, mais des précautions doivent être prises lors des tests."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications lors des tests ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "En suivant des protocoles stricts et en assurant une formation adéquate du personnel."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de maladies immunitaires ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents familiaux et certaines infections peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress, le tabagisme et une mauvaise alimentation peuvent affecter l'immunité."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils recommandés pour les personnes à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des facteurs de risque devraient envisager des tests réguliers."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies cardiaques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies auto-immunes ou d'allergies peuvent augmenter le risque."
}
}
]
}
]
}
Usak University Faculty of Arts and Sciences, Molecular Biology and Genetics Department, 1 Eylül Campus, 64300 Uşak, Turkey. Electronic address: recep.liman@usak.edu.tr.
Publications dans "Tests de cytotoxicité immunologique" :
Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. Electronic address: cperugino@mgh.harvard.edu.
Publications dans "Tests de cytotoxicité immunologique" :
We investigated whether we could have a material and sustained impact on immunology test ordering by primary care clinicians by building evidence-based and explanatory algorithms into test ordering so...
A service evaluation revealed cases of over-requesting of antinuclear antibody, allergen-specific IgE and total IgE tests, and under-requesting of urine protein electrophoresis. We conducted a quality...
We observe large (36% to 88%) reductions in testing activity (workload) for the over-requested tests and large (28%-135%) increases for the under-requested test. We show that these changes are sustain...
Embedding algorithms in the ordering software can be acceptable to clinicians and have a major and sustained impact on overuse or underuse of tests. The algorithms can be replicated by other hospital ...
To assess whether internal controls (IC) of HIV rapid tests (HRT) and a rapid confirmatory assay (Geenius) were designed to solely prevent procedural missteps or wether they can also alert for insuffi...
Thirteen tests were evaluated using distilled water, phosphate buffered saline, and HIV-1 positive serum samples : Autotest VIH® (Autotest) (AAZ-LMB), INSTI...
Among the 13 tests, 4 were invalid when tested without human serum sample: Autotest, Geenius, INSTI and MULTISURE. The Autotest and INSTI accurately labelled diluted samples, with a Test line positive...
Antivenom therapy is the only specific treatment for snakebite envenomation, and antivenom potency determination is key in the efficacy assurance quality control process. Nowadays, this process relies...
Evasion from immunity is a major obstacle to the achievement of successful cancer immunotherapy. Hybrids derived from cell-cell fusion are theoretically associated with tumor heterogeneity and progres...
The Resist Acineto from Coris Bioconcept is a novel immunochromatographic test for detection of the major acquired carbapenemases (OXA-23, OXA-40, OXA-58, and NDM) identified in Acinetobacter spp. Thi...
Due to the presumed lipolytic and anabolic properties, the misuse of human growth hormone (hGH) and its synthetic analogs in sports is prohibited both in- and out-of-competition. Within this research ...
Patch testing is the primary diagnostic approach for contact dermatitis,...
Retrospective analysis used patch testing data from 2015 to 2022....
Of the 87 patients tested, 43 had at least one positive reaction (mean age 41.7; range 19-68). Females were 33 of the total patients (76.7%). Thirteen (30%) patients had two or more positive reactions...
Triggering agents for contact dermatitis vary among geographic regions and populations. This study gives an idea of the allergens that are the most common sensitizers among the contact dermatitis popu...
Natural killer (NK) cells are important players in the human immune response. Impaired NK function may lead to serious, life-threatening conditions. Defects may be consequences of genetic mutations or...
Peripheral blood from healthy donors was taken with three anticoagulants: heparin, K...
In most cases of analyzed healthy donors, cytotoxicity results were similar regardless of type of anticoagulant. However, the highest mean values were obtained in samples with citrate. There was a sig...
Results of spontaneous NK cytotoxicity seem to be affected by the anticoagulants used for blood protection. Commercial instant cytotoxicity testing and delayed analysis after blood storage gave the hi...
Given a gradient relationship between fecal hemoglobin (f-Hb) concentration and colorectal neoplasia demonstrated previously, using f-Hb-guided interscreening interval has increasingly gained attentio...
To demonstrate the applicability of personalized colorectal cancer (CRC) screening with f-Hb-guided screening intervals to reduce the number of FITs and colonoscopy with as equivalent efficacy as univ...
A retrospective cohort study for developing f-Hb-guided precision interscreening interval was conducted using data on a Taiwanese biennial nationwide FIT screening program that enrolled more than 3 mi...
A spectrum of f-Hb-guided intervals was determined by using the Poisson regression model given the equivalent efficacy of a universal biennial screening. The use of FIT and colonoscopy for the pragmat...
Using data from the 3 500 250 participants (mean [SD] age, 57.8 [6.0] years) enrolled in the Taiwanese biennial nationwide FIT screening program, an incremental increase in baseline f-Hb associated wi...
The gradient relationship between f-Hb and colorectal neoplasia and CRC mortality was used to develop personalized FIT screening with f-Hb-guided screening intervals. Such a precision interscreening i...
The 21st-century toxicity testing program recommends the use of cytotoxicity data from human cells in culture for rapid in vitro screening focusing on biological pathways of potential toxicants to pre...